DeFloria LLC Commences Phase 1 Clinical Program for Innovative Full Spectrum Hemp Botanical Drug

December 13, 2023

Phase 1 Results to Inform Phase 2 studies in 1H24

DENVER, Dec. 13, 2023 /PRNewswire/ – (TSX:CWEB) (OTCQX: CWBHF), Charlotte’s Web Holdings, Inc. (“Charlotte’s Web,” “CW” or the “Company”), the market leader in full-spectrum hemp extract wellness products, and AJNA BioSciences PBC (“AJNA”), a botanical drug development company focused on mental health and neurological disorders, announced today that DeFloria LLC (“DeFloria”) commenced its First-in-Human Phase 1 clinical trial for AJA001, a full-spectrum botanical drug.

Read more at prnewswire.com

Related news for (CWBHF)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.